Key result
Formalin-inactivated Venezuelan equine encephalomyelitis vaccine produced in chicken embryo cells demonstrated excellent potency in mice.
Enables scalable production of inactivated VEE vaccine; leaves open immunogenicity, safety, and clinical efficacy.
Formalin-inactivated Venezuelan equine encephalomyelitis vaccine was prepared from virus grown in rolling-bottle cultures of chicken embryo cells. Trinidad strain virus was propagated in these cultures with a maintenance medium consisting of serum-free medium 199 containing 0.25% human serum albumin (USP) and antibiotics. Manipulation of multiplicity of inoculum (0.06 to 0.00006) and maintenance medium volume (100 to 300 ml) resulted in high-titered virus yields and only moderate cell destruction when fluids from infected cultures were harvested at 18 to 24 hr. The virus was inactivated at 37 C by 0.05% Formalin within 8 to 10 hr and with 0.1% Formalin within 6 to 8 hr. Single dose, antigen extinction tests in mice performed with 30 small-scale vaccine lots showed excellent potency at either Formalin concentration with inactivation periods ranging from 24 to 96 hr.
No takes yet. Share an insight, caveat, or question.
Cole et al. (1973) studied Venezuelan equine encephalomyelitis. Formalin-inactivated Venezuelan equine encephalomyelitis vaccine was evaluated on Vaccine potency in mice. Formalin-inactivated Venezuelan equine encephalomyelitis vaccine produced in chicken embryo cells demonstrated excellent potency in mice.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: